Cargando…
Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients
BACKGROUND: Cachexia‐associated skeletal muscle wasting or ‘sarcopenia’ is highly prevalent in ovarian cancer and contributes to poor outcome. Drivers of cachexia‐associated sarcopenia in ovarian cancer remain elusive, underscoring the need for novel and better models to identify tumour factors indu...
Autores principales: | Ubachs, Jorne, van de Worp, Wouter R.P.H., Vaes, Rianne D.W., Pasmans, Kenneth, Langen, Ramon C., Meex, Ruth C.R., van Bijnen, Annemarie A.J.H.M., Lambrechts, Sandrina, Van Gorp, Toon, Kruitwagen, Roy F.P.M., Olde Damink, Steven W.M., Rensen, Sander S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818657/ https://www.ncbi.nlm.nih.gov/pubmed/34951138 http://dx.doi.org/10.1002/jcsm.12885 |
Ejemplares similares
-
Sarcopenia and ovarian cancer survival: a systematic review and meta‐analysis
por: Ubachs, Jorne, et al.
Publicado: (2019) -
Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer
por: Rutten, Iris J.G., et al.
Publicado: (2017) -
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients
por: Ubachs, Jorne, et al.
Publicado: (2021) -
Human pancreatic tumour organoid‐derived factors enhance myogenic differentiation
por: Vaes, Rianne D.W., et al.
Publicado: (2022) -
Activation of the Complement System in Patients with Cancer Cachexia
por: Deng, Min, et al.
Publicado: (2021)